股票 › NAMS
新阿姆斯特丹制药 NAMS
美股市值排名 #2655
$18.90 +$0.01 (+0.05%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $18.70 -1.06%
开盘$19.10
昨收$18.89
当日区间$18.50 – $19.39
成交量1.71M
市值$2.27B
市盈率（TTM）–
股息率–
NAMS 相关新闻
匹配 NewAmsterdam Pharma 或代码 NAMS 的头条新闻，按最新排序。
- Stifel Maintains NewAmsterdam Pharma(NAMS.US) With Buy Rating, Maintains Target Price $50
- Truist Financial Maintains NewAmsterdam Pharma(NAMS.US) With Buy Rating
- H.C. Wainwright Maintains NewAmsterdam Pharma(NAMS.US) With Buy Rating, Maintains Target Price $52
- BMO Capital Maintains NewAmsterdam Pharma(NAMS.US) With Buy Rating, Maintains Target Price $58
- Truist Financial Maintains NewAmsterdam Pharma(NAMS.US) With Buy Rating, Announces Target Price $57
- William Blair Maintains NewAmsterdam Pharma(NAMS.US) With Buy Rating
- Needham Maintains NewAmsterdam Pharma(NAMS.US) With Buy Rating, Maintains Target Price $48
- A Quick Look at Today's Ratings for NewAmsterdam Pharma(NAMS.US), With a Forecast Between $50 to $52
- A Quick Look at Today's Ratings for NewAmsterdam Pharma(NAMS.US), With a Forecast Between $50 to $58
- Piper Sandler Maintains NewAmsterdam Pharma(NAMS.US) With Buy Rating, Maintains Target Price $60
- BMO Capital Initiates NewAmsterdam Pharma(NAMS.US) With Buy Rating, Announces Target Price $58
- RBC Capital Maintains NewAmsterdam Pharma(NAMS.US) With Buy Rating, Raises Target Price to $51 正面
- Guggenheim Maintains NewAmsterdam Pharma(NAMS.US) With Buy Rating, Maintains Target Price $45
- A Quick Look at Today's Ratings for NewAmsterdam Pharma(NAMS.US), With a Forecast Between $45 to $48
- H.C. Wainwright Sticks to Their Buy Rating for NewAmsterdam Pharma Company (NAMS)
暂无评论——快来第一个聊聊 NAMS。
登录后参与讨论。